The forecasted data for trachea, bronchus, or lung malignant neoplasms mortality among women in the US suggests a continuous yearly decrease from 34.1 in 2024 to 30.5 in 2028 per hundred thousand women. In 2023, the mortality rate stood at 35.0. The year-on-year percentage decreases are approximately -2.64% in 2024-2025, -2.71% in 2025-2026, -2.79% in 2026-2027, and roughly -2.87% in 2027-2028. The estimated CAGR for the period 2024-2028 is about -2.75%.

Future trends to watch for include the impact of advancements in early detection, changes in smoking habits, and improvements in treatment options, which may further influence the decline in mortality rates.

Download as XLS

More about Lung Cancer Industry 2025-2029